Harmony and BLyS in Europe and the UK.
Marks & Clerk LLP, 62-68 Hills Road, Cambridge, CB2 1LA, UK. gwilliams@marks-clerk.com.
Gareth
G
Williams
D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D053264:B-Cell Activating Factor / Q000276:immunology*; D001709:Biotechnology / Q000331:legislation & jurisprudence; D030881:Disclosure; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D005060:Europe; D006801:Humans; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D006113:United Kingdom
D061067:Antibodies, Monoclonal, Humanized; D053264:B-Cell Activating Factor; C505719:TNFSF13B protein, human; C511911:belimumab